154 related articles for article (PubMed ID: 12397747)
1. Perioperative detection of circulating cancer cells in patients with colorectal hepatic metastases.
Uchikura K; Ueno S; Takao S; Miyazono F; Nakashima S; Tokuda K; Nakajo A; Matsumoto M; Aiko T
Hepatogastroenterology; 2002; 49(48):1611-4. PubMed ID: 12397747
[TBL] [Abstract][Full Text] [Related]
2. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer.
Bessa X; Elizalde JI; Boix L; Piñol V; Lacy AM; Saló J; Piqué JM; Castells A
Gastroenterology; 2001 Apr; 120(5):1084-92. PubMed ID: 11266372
[TBL] [Abstract][Full Text] [Related]
3. Safety and utility of autologous blood transfusion for resection of metastatic liver tumor.
Obayashi T; Taniguchi H; Mugitani T; Koh T; Kitagawa K; Kunishima S; Yamaguchi A; Yamagishi H
Hepatogastroenterology; 2001; 48(39):812-7. PubMed ID: 11462930
[TBL] [Abstract][Full Text] [Related]
4. Detection of carcinoembryonic antigen messenger RNA-expressing cells in portal and peripheral blood during surgery does not influence relapse in colorectal cancer.
Sadahiro S; Suzuki T; Ishikawa K; Saguchi T; Maeda Y; Yasuda S; Makuuchi H; Yurimoto S; Murayama C
Ann Surg Oncol; 2005 Dec; 12(12):988-94. PubMed ID: 16244799
[TBL] [Abstract][Full Text] [Related]
5. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
6. Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer.
Vlems FA; Diepstra JH; Punt CJ; Ligtenberg MJ; Cornelissen IM; van Krieken JH; Wobbes T; van Muijen GN; Ruers TJ
Br J Surg; 2003 Aug; 90(8):989-95. PubMed ID: 12905553
[TBL] [Abstract][Full Text] [Related]
7. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.
Sadahiro S; Suzuki T; Maeda Y; Yurimoto S; Yasuda S; Makuuchi H; Kamijo A; Murayama C
Ann Surg Oncol; 2007 Mar; 14(3):1092-8. PubMed ID: 17200912
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
9. Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma.
Allen-Mersh TG; McCullough TK; Patel H; Wharton RQ; Glover C; Jonas SK
Br J Surg; 2007 Jan; 94(1):96-105. PubMed ID: 17058316
[TBL] [Abstract][Full Text] [Related]
10. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.
Viganò L; Ferrero A; Lo Tesoriere R; Capussotti L
Ann Surg Oncol; 2008 Sep; 15(9):2458-64. PubMed ID: 18463927
[TBL] [Abstract][Full Text] [Related]
11. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.
Yoon SS; Kim SH; Gonen M; Heffernan NM; Detwiller KY; Jarnagin WR; D'Angelica M; Blumgart LH; Tanabe KK; Dematteo RP
Ann Surg Oncol; 2006 Mar; 13(3):353-62. PubMed ID: 16474912
[TBL] [Abstract][Full Text] [Related]
12. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
Posner MC; Niedzwiecki D; Venook AP; Hollis DR; Kindler HL; Martin EW; Schilsky RL; Goldberg RM; Mayer RJ
Ann Surg Oncol; 2008 Jan; 15(1):158-64. PubMed ID: 18008108
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer.
Nakashima S; Natsugoe S; Matsumoto M; Miyazono F; Nakajo A; Uchikura K; Tokuda K; Ishigami S; Baba M; Takao S; Aikou T
Surgery; 2003 Feb; 133(2):162-9. PubMed ID: 12605177
[TBL] [Abstract][Full Text] [Related]
14. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study.
Oussoultzoglou E; Rosso E; Fuchshuber P; Stefanescu V; Diop B; Giraudo G; Pessaux P; Bachellier P; Jaeck D
Arch Surg; 2008 Dec; 143(12):1150-8; discussion 1158-9. PubMed ID: 19075165
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment for colorectal liver metastases involving the paracaval portion of the caudate lobe.
Yamamoto H; Nagino M; Kamiya J; Hayakawa N; Nimura Y
Surgery; 2005 Jan; 137(1):26-32. PubMed ID: 15614278
[TBL] [Abstract][Full Text] [Related]
16. Role of hepatectomy in treating multiple bilobar colorectal cancer metastases.
Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Togo S
Surgery; 2008 Feb; 143(2):259-70. PubMed ID: 18242343
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases.
Takahashi S; Inoue K; Konishi M; Nakagouri T; Kinoshita T
Surgery; 2003 Jun; 133(6):627-34. PubMed ID: 12796730
[TBL] [Abstract][Full Text] [Related]
18. Predictive models in colorectal liver metastases--can we personalize treatment and outcome?
Welsh FK; Tekkis PP; John TG; Rees M
Dig Surg; 2008; 25(6):406-12. PubMed ID: 19212112
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
20. Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients.
Staritz P; Kienle P; Koch M; Benner A; von Knebel Doeberitz M; Rudi J; Weitz J
J Exp Clin Cancer Res; 2004 Dec; 23(4):633-9. PubMed ID: 15743034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
